Patient Leaflet Updated 28-Jun-2023 | Seacross Pharmaceuticals Ltd
Pemetrexed 100 mg/500 mg powder for concentrate for solution for infusion
Pemetrexed Seacross 100 mg powder for concentrate for solution for infusion
Pemetrexed Seacross 500 mg powder for concentrate for solution for infusion
pemetrexed
1. What Pemetrexed Seacross is and what it is used for
2. What you need to know before you use Pemetrexed Seacross
3. How to use Pemetrexed Seacross
4. Possible side effects
5. How to store Pemetrexed Seacross
6. Contents of the pack and other information
Pemetrexed Seacross is a medicine used in the treatment of cancer.
This medicine is given in combination with cisplatin, another anti-cancer medicine, as treatment for malignant pleural mesothelioma, a form of cancer that affects the lining of the lung, to patients who have not received prior chemotherapy.
It is also given in combination with cisplatin for the initial treatment of patients with advanced stage of lung cancer.
Pemetrexed Seacross can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy.
This medicine is also a treatment for patients with advanced stage of lung cancer whose disease has progressed after other initial chemotherapy has been used.
Talk to your doctor, hospital pharmacist or nurse before using Pemetrexed Seacross.
This medicine should not be used in children or adolescents, since there is no experience with this medicine in children and adolescents under 18 years of age.
Tell your doctor if you are taking any medicine for pain or inflammation (swelling), such as medicines called “nonsteroidal anti-inflammatory drugs” (NSAIDs), including medicines purchased without a doctor’s prescription (such as ibuprofen). There are many sorts of NSAIDs with different durations of activity.
Based on the planned date of your infusion of pemetrexed and/or on the status of your kidney function, your doctor needs to advise you on which medicines you can take and when you can take them. If you are unsure, ask your doctor or pharmacist if any of your medicines are NSAIDs.
Tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Pregnancy
The use of Pemetrexed Seacross should be avoided during pregnancy. Your doctor will discuss with you the potential risk of taking this medicine during pregnancy. Women must use effective contraception during treatment with pemetrexed and for 6 months after receiving the last dose.
Breast-feeding
Breast-feeding must be discontinued during pemetrexed treatment.
Fertility
Men are advised not to father a child during and up to 3 months following treatment with pemetrexed and should therefore use effective contraception during treatment with pemetrexed and for up to 3 months afterwards. If you would like to father a child during the treatment or in the 3 months following receipt of treatment, seek advice from your doctor or pharmacist.
Pemetrexed can affect your ability to have children. Talk to your doctor to seek advice about sperm storage before starting your therapy.
Pemetrexed Seacross may make you feel tired. Be careful when driving a car or using machines.
Pemetrexed Seacross 100 mg contains less than 1 mmol (11 mg) sodium per vial and is therefore considered essentially “sodium-free”.
Pemetrexed Seacross 500 mg contains approximately 2.35 mmol (54 mg) sodium (main component of cooking/table salt) per vial. This is equivalent to 2,7 % of the recommended maximum daily dietary intake of sodium for an adult.
Always use this medicine exactly as your doctor or pharmacist has told you.
Check with your doctor or pharmacist if you are not sure.
The dose of Pemetrexed Seacross is 500 milligrams for every square metre of your body’s surface area. Your height and weight are measured to work out the surface area of your body.
Your doctor will use this body surface area to work out the right dose for you. This dose may be adjusted, or treatment may be delayed depending on your blood cell counts and on your general condition.
A hospital pharmacist, nurse or doctor will have mixed the Pemetrexed Seacross powder with 9 mg/ml (0.9 %) sodium chloride solution for injection before it is given to you.
You will always receive Pemetrexed Seacross by infusion into one of your veins. The infusion will last approximately 10 minutes.
When using Pemetrexed Seacross in combination with cisplatin:
The doctor or hospital pharmacist will work out the dose you need based on your height and weight. Cisplatin is also given by infusion into one of your veins, and is given approximately 30 minutes after the infusion of pemetrexed has finished. The infusion of cisplatin will last approximately 2 hours.
You should usually receive your infusion once every 3 weeks.
Additional medicines:
Corticosteriods: your doctor will prescribe you steroid tablets (equivalent to 4 milligram of dexamethasone twice a day) that you will need to take on the day before, on the day of, and the day after pemetrexed treatment. This medicine is given to you to reduce the frequency and severity of skin reactions that you may experience during your anticancer treatment.
Vitamin supplementation: your doctor will prescribe you oral folic acid (vitamin) or a multivitamin containing folic acid (350 to 1000 micrograms) that you must take once a day while you are taking pemetrexed. You must take at least 5 doses during the seven days before the first dose of pemetrexed. You must continue taking the folic acid for 21 days after the last dose of pemetrexed. You will also receive an injection of Vitamin B12 (1000 micrograms) in the week before administration of pemetrexed and then approximately every 9 weeks (corresponding to 3 courses of pemetrexed treatment). Vitamin B12 and folic acid are given to you to reduce the possible toxic effects of the anticancer treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You must contact your doctor immediately if you notice any of the following:
Side effects with pemetrexed may include:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (affect up to 1 of 10,000 people)
Not known: frequency cannot be estimated from the available data
You might have any of these symptoms and/or conditions. You must tell your doctor as soon as possible when you start experiencing any of these side effects.
If you are concerned about any side effects, talk to your doctor.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the leaflet.
You can also report side effects directly via
or
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton & vial after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Reconstituted and diluted infusion solutions: When prepared as directed, chemical and physical in-use stability of reconstituted and further diluted infusion solutions of pemetrexed were demonstrated for 24 hours at 25°C and at refrigerated temperature (2-8°C). From microbiological point of view, the product should be used immediately.
This medicine is for single use only; any unused solution must be disposed of in accordance with local requirement.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
After reconstitution, the solution contains 25 mg/ml of pemetrexed. Further dilution by a healthcare provider is required prior to administration.
Pemetrexed Seacross is a powder for concentrate for solution for infusion in a vial. It is a white to either light yellow or green-yellow lyophilised powder; a clear, colorless to yellow or yellow-green colored solution, once reconstituted.
Each pack of Pemetrexed Seacross consists of one vial.
This medicinal product is authorised in the Member States of the EEA under the following names:
BG:
Pemetrexed Novamed 100 mg Прах за концентрат за инфузионен разтвор
Pemetrexed Novamed 500 mg Прах за концентрат за инфузионен разтвор
DE
Pemetrexed Seacross 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pemetrexed Seacross 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
IE
Pemetrexed Seacross 100 mg powder for concentrate for solution for infusion
Pemetrexed Seacross 500 mg powder for concentrate for solution for infusion
RO
Pemetrexed Seacross 100 mg Pulbere pentru concentrat pentru soluţie perfuzabilă
Pemetrexed Seacross 500 mg Pulbere pentru concentrat pentru soluţie perfuzabilă
CY
Pemetrexed Seacross 100 mg κόνις για πυκνό διάλυμα για παρασκευή διαλύματος προς έγχυση
Pemetrexed Seacross 500 mg κόνις για πυκνό διάλυμα για παρασκευή διαλύματος προς έγχυση
This leaflet was last revised in 02/2023
Stanmore Place, Honeypot Lane, Stanmore, London, HA7 1BT
+44 (0)203 727 0712
+44 (0)203 727 0712
+44 (0)208 731 5273
+44 (0208 731 5273
+44 (0)208 731 5273
http://www.seacrosspharma.com